asenapine has been researched along with Acathisia, Drug-Induced in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellino, S; Bozzatello, P; Rocca, P; Uscinska, M | 1 |
Einat, H; Ene, HM; Kara, NZ | 1 |
Caballero, J; Harrington, CA; Thomas, JE | 1 |
Hundt, C; Kelly, L; Landbloom, R; Mackle, M; Mathews, M; McIntyre, RS; Snow-Adami, L; Wu, X | 1 |
Alphs, L; Cohen, M; Kane, JM; Panagides, J; Zhao, J | 1 |
Citrome, L | 1 |
Hopkins, CR | 1 |
2 review(s) available for asenapine and Acathisia, Drug-Induced
Article | Year |
---|---|
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis.
Topics: Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Aripiprazole; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Incidence; Lurasidone Hydrochloride; Schizophrenia | 2015 |
Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lurasidone Hydrochloride; Piperidines; Schizophrenia; Thiazoles | 2011 |
3 trial(s) available for asenapine and Acathisia, Drug-Induced
Article | Year |
---|---|
Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Hypesthesia; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Weight Gain; Young Adult | 2017 |
Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzocycloheptenes; Disease Progression; Disorders of Excessive Somnolence; Dizziness; Double-Blind Method; Dysgeusia; Europe; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Hypesthesia; Least-Squares Analysis; Male; Mouth Diseases; Olanzapine; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain | 2017 |
Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Dibenzocycloheptenes; Double-Blind Method; Female; Haloperidol; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Parkinsonian Disorders; Schizophrenia; Treatment Outcome | 2010 |
2 other study(ies) available for asenapine and Acathisia, Drug-Induced
Article | Year |
---|---|
The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors.
Topics: Akathisia, Drug-Induced; Amphetamine; Anhedonia; Animals; Antimanic Agents; Antipsychotic Agents; Appetitive Behavior; Bipolar Disorder; Central Nervous System Stimulants; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Exploratory Behavior; Food Preferences; Heterocyclic Compounds, 4 or More Rings; Male; Mice; Models, Animal; Motor Activity; Neuropsychological Tests; Saccharin; Social Behavior | 2015 |
ACS chemical neuroscience molecule spotlight on Saphris.
Topics: Administration, Sublingual; Akathisia, Drug-Induced; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Structure; Receptors, Neurotransmitter; Schizophrenia | 2010 |